Catherine Skari
-
Jan- 2026 -26 JanuaryNews
U.S. Exit from WHO | Implications for Global Health Cooperation and Preparedness
The U.S. government said the decision was based on concerns about how the WHO handled previous global health emergencies, particularly…
Read More » -
19 JanuaryClinical News
SICKLE CELL DISEASE | Alzheimer’s Drug Demonstrates Potential Therapeutic Benefit
The study explores the potential of memantine, a medication that has been safely used for many years in the treatment…
Read More » -
4 January
-
Dec- 2025 -27 DecemberClinical News
FDA APPROVES AQVESME™ (mitapivat) | First Oral Therapy for Anaemia Across All Forms of Thalassaemia
This regulatory decision marks a landmark milestone in the management of thalassaemia, as AQVESME is now the first and only…
Read More » -
17 DecemberNews
PUTTING PATIENTS FIRST IN CLINICAL RESEARCH | New EU Recommendations to Reduce Trials Bureaucracy
As Prof. Martin Dreyling, Chair of the Coalition for Reducing Bureaucracy, explains: “The current safety requirements for investigators are disproportionately…
Read More » -
12 DecemberNews
EU AGREES LANDMARK REFORM OF PHARMACEUTICAL LEGISLATION | What It Means for Patients and Public Health
This milestone agreement — part of what has been referred to as the “pharma package” — was negotiated between the…
Read More » -
9 DecemberScientific Literature
National Thalassemia Registry: A 30-year Journey of implementing Carrier Screening in Singapore
Introduction Haemoglobinopathies, which include thalassemia and structural haemoglobin variants, are the most common inherited disease affecting an estimated 20% of the world’s population.…
Read More » -
9 December
-
Nov- 2025 -21 NovemberTIF News
1st TIF NURSING WORKSHOP ON HAEMOGLOBINOPATHIES | 29-30 November 2025
📌 Workshop Title: 1st TIF Nursing Workshop on Haemoglobinopathies 📌 Date & Venue: Saturday & Sunday, 29-30 November 2025 |…
Read More » -
Oct- 2025 -20 OctoberNews
TOPICS IN FOCUS SERIES | Guidelines for the Management of Thalassaemia Syndromes
Each booklet focuses on a specific aspect of the updated guidelines for transfusion-dependent thalassaemia (TDT), non-transfusion-dependent β-thalassaemia (NTDT), and α-thalassaemia,…
Read More »

